Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase NA 1

Status

Terminated 1Not yet recruiting 1Enrolling by invitation 1Active not recruiting 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 4Observational 1

Sponsor

Conditions

Breast Neoplasms 2419Neoplasms 1838Carcinoma, Non-Small-Cell Lung 1591Prostatic Neoplasms 1296Colorectal Neoplasms 1117Lung Neoplasms 981Neoplasm Metastasis 828Multiple Myeloma 793Leukemia, Myeloid, Acute 773Ovarian Neoplasms 673Pancreatic Neoplasms 667Melanoma 660Squamous Cell Carcinoma of Head and Neck 589Recurrence 563Carcinoma, Hepatocellular 562Brain Neoplasms 515Glioblastoma 505Stomach Neoplasms 501Head and Neck Neoplasms 492Triple Negative Breast Neoplasms 471Lymphoma 460Uterine Cervical Neoplasms 444Carcinoma, Renal Cell 426Precursor Cell Lymphoblastic Leukemia-Lymphoma 420Lymphoma, Non-Hodgkin 387Endometrial Neoplasms 377Sarcoma 365Lymphoma, Follicular 357Urinary Bladder Neoplasms 356Lymphoma, Large B-Cell, Diffuse 355

Interventions

ruxolitinib 1ceterizine hydrochloride 1capivasertib 1Sirolimus 1Loperamide 1Fulvestrant 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Interventional × Exanthema × 1 year × Clear all
NCT06399029 2026-04-30

TRUX-LST

University of Zurich

Phase 2 Active not recruiting
22 enrolled

Exanthema

NCT07476807 2026-04-28

TREATS

Sligo General Hospital

Phase NA Enrolling by invitation
25 enrolled

Exanthema

NCT07426822 2026-02-24

SAFE-CAP

Yale University

Phase 2 Not yet recruiting
108 enrolled

Diarrhea, Exanthema

NCT03363763 2025-12-01

Topical Sirolimus Ointment for Cutaneous Angiofibromas in Subjects With Tuberous Sclerosis Complex

Aucta Pharmaceuticals, Inc

Phase 2 Terminated
24 enrolled 11 charts

Erythema, Exanthema, Fibroma, Tuberous Sclerosis, Facies

Data powered by HemOnc (CC BY 4.0) Colophon âš¡